On June 2, 2021 Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, reported that Chairman and Chief Executive Officer, Quanterix, Kevin Hrusovsky will be delivering a virtual presentation at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10th at 3:50pm ET (Press release, Quanterix, JUN 2, 2021, View Source [SID1234583418]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Attendees can access the public webcast at View Source or by visiting the News & Events page within the Investors section of the Quanterix website at View Source Replays of the webcast will be available on the Quanterix website for 90 days following the conference.

Additionally, Hrusovsky will appear on the June 3 episode of The Bio Report, a leading podcast that focuses on the intersection of biotechnology and business, science, and policy. The episode, which airs at 4:00 p.m., EDT, will be available to listen on demand at http://thebioreport.com/ or through the following podcast providers: Apple Podcasts, iHeart Radio, Google Podcasts, Soundcloud, and Stitcher.